Modulating Glycolysis to Improve Cancer Therapy.

Chelakkot C, Chelakkot VS, Shin Y, Song K. · 2023

Read Modulating Glycolysis to Improve Cancer Therapy. by Chelakkot C, Chelakkot VS, Shin Y, Song K. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9916680.txt.

Description

Chelakkot and co-authors explore how changing glycolysis could improve cancer therapy. Cancer cells shift to a glycolysis-dominant profile to gain energy and building blocks. This shift is known as the Warburg effect. It also makes the tumor setting more pro-cancer and raises drug and radiation resistance.

Immune cells in tumors make a like shift, so both cell types compete for nutrients. Blocking high glycolysis may leave cancer cells open to other treatments. Options include chemotherapy, radiotherapy, hormone therapy, immunotherapy, and photodynamic therapy. Many targeting tactics sit in preclinical or clinical testing. Few yet hit cancer glycolysis with enough precision. The review weighs what is known and what still blocks progress.

Catalog record

CREATORChelakkot C, Chelakkot VS, Shin Y, Song K.
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE162 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC9916680

Browse the full library · About the Tower of Babel